These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3901256)

  • 21. [Clinical use of DNA-recombinant human growth hormone].
    Dedov II
    Probl Endokrinol (Mosk); 1993; 39(5):65-7. PubMed ID: 8108355
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone.
    Gibbs CJ; Joy A; Heffner R; Franko M; Miyazaki M; Asher DM; Parisi JE; Brown PW; Gajdusek DC
    N Engl J Med; 1985 Sep; 313(12):734-8. PubMed ID: 2863752
    [No Abstract]   [Full Text] [Related]  

  • 23. A further British case of growth hormone induced Creutzfeldt-Jakob disease.
    Ellis CJ; Katifi H; Weller RO
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1200-2. PubMed ID: 1479400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of hypophyseal nanism].
    Tamburrano G; Grossi A
    Minerva Endocrinol; 1990; 15(1):55-60. PubMed ID: 2274015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Point of view: therapy with growth hormone.
    Page LA; Orson JM
    R I Med; 1995 Nov; 78(11):326. PubMed ID: 8547725
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prions, Jakob-Creutzfeldt disease and human growth hormone].
    González PM
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(5):207-9. PubMed ID: 3296112
    [No Abstract]   [Full Text] [Related]  

  • 27. Problems with growth hormone.
    Med Lett Drugs Ther; 1985 Jul; 27(691):57-8. PubMed ID: 3892258
    [No Abstract]   [Full Text] [Related]  

  • 28. Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone.
    Koch TK; Berg BO; De Armond SJ; Gravina RF
    N Engl J Med; 1985 Sep; 313(12):731-3. PubMed ID: 3897861
    [No Abstract]   [Full Text] [Related]  

  • 29. Creutzfeldt-Jakob verdict may prompt new claims.
    Carr K
    Nature; 1993 Nov; 366(6451):98. PubMed ID: 8232564
    [No Abstract]   [Full Text] [Related]  

  • 30. [The therapeutic problem in pituitary dwarfism. Personal contribution].
    Conti C; Isidori A
    Folia Endocrinol; 1968 Oct; 21(5):559-76. PubMed ID: 5756726
    [No Abstract]   [Full Text] [Related]  

  • 31. Human growth hormone distribution discontinued.
    FDA Drug Bull; 1985 Aug; 15(2):17-8. PubMed ID: 3902547
    [No Abstract]   [Full Text] [Related]  

  • 32. [Growth hormone and Creutzfeldt-Jakob disease].
    Goujard J
    Rev Epidemiol Sante Publique; 1993; 41(6):513-4. PubMed ID: 8296041
    [No Abstract]   [Full Text] [Related]  

  • 33. [Genotropin in the treatment of children with growth hormone deficiency].
    Kasatkina EP; Sokolovskaia VN; Murankova NM; Ibragimov GV
    Probl Endokrinol (Mosk); 1993; 39(5):94-6. PubMed ID: 8108362
    [No Abstract]   [Full Text] [Related]  

  • 34. Human growth hormone treatment and Creutzfeldt-Jakob disease.
    Sartorio A; Arosio M; Faglia G; Resentini M; Morabito F
    J Endocrinol Invest; 1986 Oct; 9(5):439. PubMed ID: 3540083
    [No Abstract]   [Full Text] [Related]  

  • 35. [The risk in using growth hormone obtained from human pituitary glands].
    Romer T
    Endokrynol Pol; 1986; 37(4):189-91. PubMed ID: 3549269
    [No Abstract]   [Full Text] [Related]  

  • 36. [Iatrogenic Creutzfeldt-Jakob disease. Lessons from cases secondary to extracted growth hormone in France].
    Billette de Villemeur T; Pradel A
    Transfus Clin Biol; 1994; 1(5):333-7. PubMed ID: 7812459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy in dwarfism. Use of genetically produced growth hormone in practice].
    Neugebauer M
    Med Monatsschr Pharm; 1986 Nov; 9(11):345-6. PubMed ID: 3543630
    [No Abstract]   [Full Text] [Related]  

  • 38. The decline and fall of Creutzfeldt-Jakob disease associated with human growth hormone therapy.
    Brown P
    Neurology; 1988 Jul; 38(7):1135-7. PubMed ID: 3290705
    [No Abstract]   [Full Text] [Related]  

  • 39. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand.
    Croxson M; Brown P; Synek B; Harrington MG; Frith R; Clover G; Wilson J; Gajdusek DC
    Neurology; 1988 Jul; 38(7):1128-30. PubMed ID: 3290702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal proteins in the cerebrospinal fluid of a patient with Creutzfeldt-Jakob disease following administration of human pituitary growth hormone.
    Macário ME; Moura-Neto V; Vaisman M; Araujo HM; Buescu A; Cordeiro JG; Chagas C
    Braz J Med Biol Res; 1992; 25(11):1127-30. PubMed ID: 1342593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.